Metformin lowers blood sugar primarily by making your cells more responsive to insulin, the hormone that moves glucose out of your bloodstream and into your tissues. It increases whole-body glucose disposal rates by about 20%, which means your muscles and other tissues pull sugar from the blood more efficiently after a meal. But its effects reach well beyond blood sugar. Metformin changes how your gut works, influences your weight, and affects nutrient absorption in ways that matter whether you’ve just started taking it or have been on it for years.
How It Improves Blood Sugar
Metformin works on multiple fronts at once. In your liver, it dials down the constant production of glucose that happens between meals, which is a major reason blood sugar runs high in type 2 diabetes. In your muscles, it helps insulin do its job better, so glucose gets pulled into cells instead of lingering in your blood. These two effects together are why metformin is typically the first medication prescribed for type 2 diabetes.
There’s also a lesser-known mechanism happening in your intestines. Metformin directly stimulates specialized cells in your gut lining to release a hormone called GLP-1, which lowers blood sugar after meals and promotes a feeling of fullness. Research published in JCI Insight confirmed that metformin acts directly on these gut cells, not just indirectly through other pathways. Part of this effect comes from metformin changing how bile acids are absorbed in the small intestine, which in turn triggers more GLP-1 release further down the digestive tract. This gut-level action helps explain why metformin’s effects feel different from medications that only target the liver or pancreas.
Effects on Weight
Metformin produces modest weight loss, not dramatic changes. In clinical trials, people taking metformin lost an average of about 2 kilograms (roughly 4.4 pounds) over 12 months, compared to less than 1 kilogram with placebo. Weight loss typically begins after about four weeks and occurs mainly during the first 6 to 12 months of treatment.
The effect is more pronounced in people with higher body weight. Those with a BMI above 35 saw greater results, and doses above 1,500 mg per day were more effective than lower doses. The GLP-1 boost from metformin likely plays a role here, since that hormone promotes satiety and can reduce appetite. If you’re hoping metformin will replace diet and exercise for weight management, the numbers suggest it’s a helpful addition but not a standalone solution.
What Happens in Your Gut
Digestive side effects are the most common reason people struggle with metformin, especially in the first weeks. A meta-analysis of observational studies found diarrhea in about 7% of users, bloating in 6%, abdominal pain in 5%, and vomiting in about 2%. Constipation affected roughly 1%. These numbers reflect ongoing use, but symptoms tend to be more intense when you first start and often improve as your body adjusts.
If stomach issues are a problem, switching from the standard immediate-release tablet to the extended-release version can make a significant difference. In one study, patients who switched saw their overall gastrointestinal symptom scores drop from 44.5 to 28.4 on a standardized scale, and diarrhea scores fell by more than half. Fourteen out of 16 patients improved within two weeks of making the switch. Starting at a low dose and increasing gradually also helps, which is why most prescribers ramp up the dose over several weeks rather than starting at the full amount.
Vitamin B12 and Long-Term Nutrient Absorption
One of metformin’s less obvious effects is that it interferes with your body’s ability to absorb vitamin B12 from food. This doesn’t cause problems right away, but over years of use, B12 levels can drop low enough to cause symptoms. Studies estimate that 10% to 30% of long-term metformin users develop B12 deficiency, with higher doses and longer duration increasing the risk. One study found that 35% of diabetic patients on metformin were B12 deficient, with average levels well below the normal range.
B12 deficiency can cause fatigue, numbness or tingling in the hands and feet, memory problems, and difficulty with balance. These symptoms overlap with diabetic neuropathy, which means they can easily be mistaken for worsening diabetes rather than a correctable vitamin shortage. If you’ve been on metformin for more than a year or two, periodic B12 blood tests are worth discussing with your provider, and a simple supplement can prevent or reverse the problem.
How It Affects Your Kidneys
Metformin itself doesn’t damage the kidneys, but your kidneys are responsible for clearing it from your body. If kidney function declines, metformin can accumulate to levels that become unsafe. Current guidelines use a blood test called eGFR (estimated glomerular filtration rate) to determine whether metformin is appropriate. When eGFR drops below 45, the dose may need to be reduced and kidney function monitored more closely. Below 30, metformin is contraindicated entirely.
The concern with impaired clearance is a rare but serious condition called lactic acidosis, where acid builds up in the blood. The reported rate is about 6 cases per 100,000 patient-years of use, and it occurs almost exclusively in people who have other risk factors like severe kidney disease, liver problems, or conditions that reduce oxygen delivery to tissues. For people with normal kidney function, this risk is extremely low.
Beyond Blood Sugar: Aging Research
Metformin has attracted attention for potential effects that go beyond diabetes. Researchers have observed that people with diabetes who take metformin sometimes have lower rates of certain cancers and cardiovascular disease compared to what would be expected. This has fueled interest in whether metformin affects the aging process itself.
A completed trial called MILES (Metformin in Longevity Study) tested whether six weeks of metformin could change gene expression patterns in muscle and fat tissue, looking for shifts in the biological signatures associated with aging. A much larger trial called TAME (Targeting Aging with Metformin) aims to test whether metformin can delay age-related diseases in older adults without diabetes. These studies are investigating metformin’s potential cellular effects, including its activation of an energy-sensing pathway that influences how cells repair themselves and manage stress. Results from TAME will help clarify whether the patterns seen in observational data reflect a real anti-aging benefit or simply the effects of better blood sugar control.